This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Xeris Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Brett Newswanger: Innovator in Diabetes Treatment
Introduction
Brett Newswanger is a notable inventor based in Chicago, IL, who has made significant contributions to the field of diabetes treatment. His innovative approach focuses on addressing exercise-induced hypoglycemia, a condition that can affect individuals with type 1 and type 2 diabetes.
Latest Patents
Brett holds a patent for the "Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes." This patent outlines methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia. The invention involves administering a formulation of glucagon or glucagon analog to a subject in need, effectively managing their condition. The administration can occur 1, 5, 10, 15 to 20, or even 30 minutes prior to exercise, providing a proactive approach to managing hypoglycemia.
Career Highlights
Brett is currently associated with Xeris Pharmaceuticals, Inc., where he continues to develop innovative solutions for diabetes management. His work is pivotal in enhancing the quality of life for individuals living with diabetes, particularly those who experience hypoglycemic episodes during physical activity.
Collaborations
Brett collaborates with Martin Cummins, leveraging their combined expertise to advance research and development in diabetes treatment. Their partnership exemplifies the importance of teamwork in driving innovation in the medical field.
Conclusion
Brett Newswanger's contributions to diabetes treatment through his patented methods highlight the critical role of innovation in healthcare. His work not only addresses a significant medical challenge but also showcases the potential for advancements in the management of chronic conditions.